Owens, Dominic D. G.
Anselmi, Giorgio http://orcid.org/0000-0002-8870-3354
Oudelaar, A. Marieke http://orcid.org/0000-0002-4016-6158
Downes, Damien J. http://orcid.org/0000-0002-5034-0869
Cavallo, Alessandro http://orcid.org/0000-0002-0135-0032
Harman, Joe R. http://orcid.org/0000-0003-3668-1859
Schwessinger, Ron http://orcid.org/0000-0001-7829-8503
Bucakci, Akin
Greder, Lucas
de Ornellas, Sara
Jeziorska, Danuta
Telenius, Jelena
Hughes, Jim R. http://orcid.org/0000-0002-8955-7256
de Bruijn, Marella F. T. R. http://orcid.org/0000-0002-4934-4125
Funding for this research was provided by:
RCUK | Medical Research Council (MC_UU_12009/2, MC_UU_12009/2)
Article History
Received: 8 June 2021
Accepted: 12 January 2022
First Online: 9 February 2022
Competing interests
: J.R.Hu and D.J. are founders and shareholders of, and D.J.D. and R.S. are paid consultants for Nucleome Therapeutics. Other authors declare no competing interests.